Yan, Y., He, Y., Wang, G., Cao, L., Luo, H., Hu, X., Chen, W., Wu, S., Li, H., Ke, L., Xu, H., Niu, J., Wang, C. (2025). Bevacizumab plus mFOLFOX6/FOLFIRI sequential bevacizumab plus capecitabine maintenance in RAS-mutated advanced colorectal cancer: A real-world study of first-line/second-line conversion therapy.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.77